Mwanzo2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Bei iliyotangulia
$ 19.82
Bei za siku
$ 19.83 - $ 20.54
Bei za mwaka
$ 12.78 - $ 29.00
Thamani ya kampuni katika soko
77.34B HKD
Wastani wa hisa zilizouzwa
2.44M
Uwiano wa bei na mapato
14.17
Mgao wa faida
1.71%
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 12.27B | 20.81% |
Matumizi ya uendeshaji wa biashara | 5.92B | 39.11% |
Mapato halisi | 847.27M | 11.59% |
Kiwango cha faida halisi | 6.91 | -7.62% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.47B | 45.62% |
Asilimia ya kodi ya mapato | 6.50% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.36B | -4.73% |
Jumla ya mali | 120.05B | 2.21% |
Jumla ya dhima | 58.21B | 1.19% |
Jumla ya hisa | 61.84B | — |
hisa zilizosalia | 2.64B | — |
Uwiano wa bei na thamani | 1.07 | — |
Faida inayotokana na mali | 1.47% | — |
Faida inayotokana mtaji | 1.78% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 847.27M | 11.59% |
Pesa kutokana na shughuli | 1.83B | 22.89% |
Pesa kutokana na uwekezaji | -633.93M | 45.98% |
Pesa kutokana na ufadhili | elfu 337.12 | 100.07% |
Mabadiliko halisi ya pesa taslimu | 1.10B | 1,382.17% |
Mtiririko huru wa pesa | 5.59B | 91.26% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,603
